Study Status:
Active
Study Description:
What is the purpose of this research study?
The purpose of this clinical trial is to evaluate the efficacy, safety and tolerability of MK-8931, a drug that may have the potential to treat Alzheimer's disease (AD). MK-8931 reduces levels of "A-beta" (a small piece of protein). A-beta may be involved in causing Alzheimer's disease.
For more details of the study, please see the attached document.
Study Coordinator(s):
Sehily JaimesTel: 617-643-5200
Email:
